Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.60 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.60 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.60 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.60 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.60 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.60 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.60 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.60 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.60 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.60 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.60 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.60 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.52 |
| ▸ | RXRA | P19793 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6208836 | 0.84 | SMN1; SMN2 (0.82) | SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4 | |
| SCHEMBL69789 | 0.82 | SMN1; SMN2 (0.78) | SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4 | |
| SCHEMBL11724879 | 0.79 | SMN1; SMN2 (0.67) | SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4 | |
| SCHEMBL7827144 | 0.78 | MAPT (0.80) | SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4 | |
| SCHEMBL7065645 | 0.78 | MAPT (0.79) | SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4 | |
| SCHEMBL31742296 | 0.77 | HSD17B10 (0.59) | SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4 | |
| SCHEMBL14720056 | 0.77 | SMN1; SMN2 (0.55) | SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4 | |
| SCHEMBL3397221 | 0.77 | P2RY6 (0.61) | SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4 | |
| SCHEMBL13712784 | 0.76 | CA2 (0.56) | HSD17B10FFAR1MAPTRXRARXRB | |
| SCHEMBL29129893 | 0.76 | SMN1; SMN2 (0.69) | SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120264925-A1 | METHOD FOR PRODUCING PYRAZOLE GLYCOSIDE DERIVATIVES | SANOFI (FR) | 2012-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120264925-A1 | METHOD FOR PRODUCING PYRAZOLE GLYCOSIDE DERIVATIVES | CYP2F1, CYP4F3, F11 | SMN1; SMN2 4009/4885HDAC3 416/4885MAPK1 1314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.